Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
about
Getting to 90-90-90 in paediatric HIV: What is needed?Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data.Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in BotswanaQuantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana.HIV-Associated Tuberculosis.Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysisCurrent integration of tuberculosis (TB) and HIV services in South Africa, 2011.Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfectionTuberculosis in HIV programmes in lower-income countries: practices and risk factorsCosts and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.Outcomes of isoniazid prophylaxis among HIV-infected children attending routine HIV care in Kenya.Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis.Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.Eligibility for isoniazid preventive therapy in South African gold mines.Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.A Qualitative Evaluation of the Acceptability of an Interactive Voice Response System to Enhance Adherence to Isoniazid Preventive Therapy Among People Living with HIV in Ethiopia.Hepatotoxicity during Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: a Secondary Analysis of a Multi-country Open-label Randomized Controlled Clinical Trial.
P2860
Q30385352-7BA9EA34-592D-4D0A-88DC-7B06BD173FCFQ30749203-F98EE460-BF42-4323-B183-AB55A2BFBD9FQ33889133-72A250FF-51AF-42FE-AB09-6323E5B9FC87Q33988089-89FFE37A-AEF5-4894-A1CC-75DB81BC6993Q34064272-D6665F8E-A6EC-4B50-A30B-4EC6A5E928FDQ34143510-8B90372B-B716-410E-9290-E4FCED6AF6EFQ34146085-C0D58731-736E-46EA-BCF8-5AB2B2871983Q34613299-BE6431CC-2EBF-4692-9BCF-386E6AD96E8AQ34914625-88972BF3-AF9D-4B6C-A716-521A18EE6FE4Q35117177-56CC656D-CD69-4F0E-BD00-F92A39479D53Q35173497-BF334AA7-9C40-4688-B216-0BFBD604A9EEQ35185440-73AFA1A6-B432-4C13-91B0-1315A19330F4Q35336540-3032824F-40DD-4919-91C6-2E94C7C115EDQ35719333-13FF2FCF-E579-4637-9D86-5C3397952E24Q36349677-B474F79B-AC69-41B2-B0DC-8730B04CC450Q36711601-07A5E454-8720-42ED-B027-BD0C9B5176B2Q37308989-75F874E7-C63A-42EB-BAD8-A2BBAF5BEF8CQ37461120-03909BA1-5FBD-4720-9E40-7AF8350D1830Q37461125-69DE70E6-7B39-46CB-8F78-16C48494FBFBQ38841837-ED4706DB-EEB5-4F7D-B77B-FE24111B4FF5Q39738755-247A6BA2-91D0-4DCC-B4BE-36E61CFF7D76Q50059794-FB688805-403E-4469-99F1-860CBC88C832
P2860
Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Isoniazid tuberculosis prevent ...... otswana Experience, 2004-2006.
@en
type
label
Isoniazid tuberculosis prevent ...... otswana Experience, 2004-2006.
@en
prefLabel
Isoniazid tuberculosis prevent ...... otswana Experience, 2004-2006.
@en
P2093
P921
P1476
Isoniazid tuberculosis prevent ...... otswana Experience, 2004-2006.
@en
P2093
Anikie Mathoma
Bafanana Chengeta
Barudi Mosimaneotsile
Charles D Wells
Oaitse I Motsamai
Samba Nyirenda
Taraz Samandari
Tefera B Agizew
P356
10.1097/QAI.0B013E3181C3CBF0
P407
P577
2010-05-01T00:00:00Z